Stock Ratings / Health Care / CNC / options

LH (73) DGX (78) ILMN (77) GH (53) ⌘ Pro Terminal →

Centene Corporation (CNC) Options Positioning, Max Pain & Unusual Sweeps

$68.45 -0.25% NYSE • Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $68.29

Centene Corporation (CNC) carries a Roarable Rating of C (Hold) with 63/100 RQD Confidence. The composite score sits in the neutral Hold band (59–69), meaning current holders don’t need to panic-sell while prospective buyers can wait for a move into the 70+ Buy zone.

📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY) →

ROARABLE C • HOLD / WATCH Cap $33.97B

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

⚡ INSTANT AI QUANT PREVIEW • $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CNC Below — or Connect Your Own ChatGPT / Claude

🤖 Mara Quenwick • AI Quant Lead (Click for Instant Brief) Is CNC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

▼

As of 2026-11-02, Centene Corporation (NYSE: CNC) is rated C (Hold / HOLD) by Roarable's 5-pillar RQD engine with a composite confidence score of 63/100 at a spot price of $68.45 (-0.25% 1D, market cap $33.97B). Pillar breakdown: Fundamental Cash Engine 11/20, Institutional 13F & Options Flow 16/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 14/20, and SEC Balance-Sheet Forensics 12/20. Across 1016 tracked Health Care issuers, CNC ranks #143 in composite RQD confidence.

✓ Pre-computed one-to-many AI Quant brief

🤖 Ellis Vennor • AI Peer & Flow Quant (Click for Instant Brief) How does CNC compare to LH and DGX in the Health Care sector?

▼

Within the Health Care sector (Medical Specialities), CNC carries a Roarable C (63/100 RQD), trailing P/E of N/A, gross margin of 8.1%, and ROIC of -31.0%. By comparison, LH (Labcorp Holdings Inc.) holds a B grade (73/100 RQD, P/E 34.0x, ROIC 8.3%, cap $29.86B) and DGX (Quest Diagnostics Incorporated) posts a B+ grade (78/100 RQD, P/E 28.1x, ROIC 10.3%, cap $27.83B). Among the 5-stock peer group, DGX leads on earnings multiple (28.1x) while ILMN leads on capital efficiency (18.2% ROIC).

✓ Pre-computed one-to-many AI Quant brief

🤖 Gideon Ashmere • AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CNC?

▼

Per CNC's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001071739), Centene Corporation generated $174.58B in revenue (+20.0% YoY), -$6.67B in net income, and $4.32B in free cash flow against $76.75B in total assets and $17.35B in total debt. Key quantitative strengths: Big institutional funds and options desks are actively positioning on the bullish side.. Primary risk factors monitored: Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.. Institutional options positioning shows a 50% call / 50% put premium split.

✓ Pre-computed one-to-many AI Quant brief

🤖 AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists — not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

EXT / AFTER-HRS: $68.29 (-0.23%)🧬 Cannibal Buyback (-1.24% YoY Shares)⚙️ Cash Engine: 11/20 (D+) • 2.5% FCF Margin

Verify 90D Bucket Audit →

📊 Historical Track Record: Scores of 63/100 (C) historically posted market-perform odds over rolling 90-day windows (+0.9% avg 90D alpha vs SPY • 54.8% hit rate — wait for RQD ≥ 70 breakout).

Audit Bucket Track Record →

RQD QUANT TACHOMETERHOLD / WATCH • C

JEV AI Jury Split (Battleground)

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw C · Rk C-

Each axis scored 0–20

12M PRICE TARGET CONE+2.2% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for CNC)Realized 20D OHLCV Swing Band: ±8.2%

Deterministic 5-Pillar Attribution (63/100 Composite)

🔍 WHY CNC SCORES 63/100 (C) — TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag

▲ #1 Bullish Driver: Whale & Options Positioning+16/20 pts (25% of score)

20D Institutional Volume Accumulation (±8.2% realized swing band)

▲ #2 Bullish Driver: Macro Regime Fit+14/20 pts (22% of score)

FRED Regime × Technicals: 90% of 52W Range • RSI-14 at 53.9 (NEUTRAL RANGE)

▼ #1 Drag / Risk Factor: SEC 10-K Forensic Risk10/20 pts (-10 pt drag)

Balance-sheet & 10-K footnote risk deducts 10 pts from forensic ceiling

📈 PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 → Q2 → Q3 → Current

Q1 (-3Q)

Grade B$68.86+2.8% Next Q

Q2 (-2Q)

Grade B-$70.81-3% Next Q

Q3 (-1Q)

Grade B-$68.71-0.4% Next Q

Current

Grade C$68.45+0.9% Hist 90D α

Trajectory: B (71) → C (63)Full Audit →

⚔️ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)GIDEON ASHMERE // FORENSIC SHORT & KILL-SWITCH DOSSIER

⚔️ Adversarial Opposing Case: Why the CNC Bull Thesis Could Fail

Gideon Ashmere Forensic Desk →

Even with a 63/100 (C) score, CNC faces multiple-compression risk if current valuation multiples re-rate toward historical sector medians or if hyperscaler/enterprise customer concentration slows in upcoming 10-Q filings.

⚠️ Forensic Kill-Switch #1

Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

⚠️ Forensic Kill-Switch #2

Dilution & Margin Drag: Cannibal Buyback (-1.24% YoY Shares) — any gross margin slip below 15.0% triggers an automatic RQD downgrade.

⚠️ Forensic Kill-Switch #3

Technical & Forensic Kill-Switch: A daily close below the 50D SMA ($66.24) or 200D SMA ($55.57) invalidates the momentum regime and cuts Target Base ($69.99) toward Bear Floor ($54.59).

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CNC• $2.4M Crowd Pool • Kalshi / Polymarket Composite

Contract: “CNC Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”

YES 63%NO 37%Trade / Inspect Odds →

CALL VS. PUT WHALE SHARE

— (No Active Options Snapshot)

Put/Call Ratio: — (No Active Options Snapshot)

MAX-PAIN EXPIRATION MAGNET

— (No Active Options Snapshot)

No active options chain max-pain snapshot on file

HISTORICAL 20D VOLATILITY SWING

±8.2%

Derived from 20D OHLCV bars (No Active Options Snapshot)

Active Strike Call vs. Put Concentration Ladder (CNC)

— (No Active Options Snapshot) — No unusual CBOE strike concentration anomalies recorded in the current database snapshot for CNC.

Sponsored / Partner SpotlightACTIVE TRADER & PROP EVALUATION DESK

Practice in Our Weekly $100,000 Paper Arena Before Risking Personal Capital

Keep your personal nest egg in cash while trading NQ, ES, Crude, and Gold momentum using institutional prop-desk buying power.

FTC Disclosure: Roarable may receive partner referral compensation at no cost to you. Partner relationships never influence RQD scores.

🏆 Enter Free $100K Paper Arena →

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher + Options & Swing Structure Desk

Whale Flow & Momentum Playbook: Evaluating CNC & AI Leaders Without Chasing Tops

✓Institutional whale strikes & implied earnings move audit on CNC
✓How disciplined traders manage risk using pre-published trigger & invalidation levels
✓Includes nightly RQD rating-change & forensic signal email alerts on tracked leaders

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

CNC // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: +27.80%📐 HORIZONTAL RANGE

2026-11-02O $67.05H $68.62L $67.05C $68.45VOL 5.63M

RES: $73.10SUP: $56.28SMA50: $66.24SMA200: $55.57

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CNC Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 CNC Butterfly Map → + Track CNC →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

27.7%/yr Implied 5Y Growth

vs. +20.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CNC today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for CNC. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for CNC today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CNC)

Health Care Rank #143 of 1016 ⚔️ LH vs CNC Full Matrix →

1. Head-to-Head Health Care Peer Comparison (CNC vs. LH, DGX, ILMN, GH)

Industry: Medical Specialities (41 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Centene Corporation (CNC) ranks #143 by composite RQD confidence (63/100, grade C) and #55 by equity capitalization ($33.97B). Within this direct 5-issuer industry benchmark cohort, DGX leads on earnings valuation at 28.1x trailing P/E, while ILMN leads on capital efficiency and profitability with 18.2% ROIC and 66.1% gross margin. DGX currently holds the highest overall quantitative score in the immediate peer group at 78/100 (B+) compared with CNC at 63/100 (C).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
CNC ACTIVE Centene Corporation	C	63/100	—	8.1%	-31.0%	-0.25%	$33.97B	Benchmark Subject
LH Labcorp Holdings Inc.	B	73/100	34.0x	28.8%	8.3%	-1.84%	$29.86B	/lh-vs-cnc →
DGX Quest Diagnostics Incorporated	B+	78/100	28.1x	33.2%	10.3%	-0.43%	$27.83B	/dgx-vs-cnc →
ILMN Illumina Inc.	B+	77/100	51.5x	66.1%	18.2%	-18.64%	$43.80B	/ilmn-vs-cnc →
GH Guardant Health Inc.	D+	53/100	—	64.5%	-17.4%	-3.51%	$24.87B	/gh-vs-cnc →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2025-12-31 • CIK 0001071739

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Centene Corporation (CNC) reported GAAP revenue of $174.58B (+20.0% vs. FY2024 revenue of $145.50B , and +24.6% cumulative change since FY2023) , GAAP net income of -$6.67B, operating cash flow of $5.09B, and free cash flow of $4.32B (+981.8% YoY). On the balance sheet, CNC closed FY2025 with $76.75B in total assets against $17.35B in total debt (Altman Z-Score: 2.52, Piotroski F-Score: 6/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2025-12-31	$174.58B	-$6.67B	$5.09B	$4.32B	$76.75B	$17.35B
FY2024 (FY)	2024-12-31	$145.50B	$3.31B	$154.0M	-$490.0M	$82.44B	$18.42B
FY2023 (FY)	2023-12-31	$140.09B	$2.70B	$8.05B	$1.75B	$168.11B	$39.34B

3. CNC Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CNC stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

How does CNC compare to LH and DGX in the Health Care sector?

What are the biggest fundamental strengths and SEC risk factors for CNC?

Where is CNC trading relative to its 50-day, 200-day, and 52-week technical levels?

CNC last traded at $68.45 (-0.25% on volume of 4,807,946 shares), positioning the stock +3.34% above its 50-day simple moving average ($66.24) and +23.18% above its 200-day simple moving average ($55.57). Across its 52-week range of $31.63 to $72.50, CNC sits at the 90.1% percentile with a 14-day RSI of 53.9 (NEUTRAL RANGE) and an implied next-earnings move of ±8.2% ($62.84 to $74.06).

CNC Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

What is CNC's options positioning and volatility profile?

Roarable tracks verified CBOE unusual options sweeps, put/call ratios, and OHLCV realized volatility bands for CNC.

Direct Sub-Reports: CNC RQD Cockpit CNC 12M Forecast CNC Earnings & Move CNC Dividends & DRIP CNC Insiders & 13F CNC Whale Options CNC Profit Sankey CNC News & Why

Sector Peer Dials

Compare →

LH B

Labcorp Holdings Inc.

73 /100

DGX B+

Quest Diagnostics Incorporated

CNC Core Snapshot

Market Cap $33.97B

Trailing / Fwd P/E — / 36.0x

Gross Profit Margin 8.1%

Return on Capital (ROIC) -31.0%

Free Cash Flow Yield 12.72%

12M Base Price Target $69.99

FREE TRADER TOOLS

Own CNC Alongside Other Stocks? Run a 30-Second Crash X-Ray

Drop 3–5 tickers into our live Portfolio X-Ray to spot hidden accounting time-bombs and see your composite RQD dial.

⚡ X-Ray My Portfolio With CNC → 🏆 Trade CNC in $100K Prop Arena →

CNC Wire

Why It Moved →

Direct Company Event Yahoo! Finance Canada • 6h ago

Centene Corporation (CNC) Stock Price, News, Quote & History

Direct Company Event Investing.com • 9h ago

Centene Stock Price Today | NYSE: CNC Live

Peer / Ecosystem Wire CNN • 12h ago

symbol__ Stock Quote Price and Forecast

Direct Company Event Yahoo Finance • 15h ago

Centene (CNC) Stock Trades Up, Here Is Why

Peer / Ecosystem Wire TradingView • 18h ago

Centene Stock Approaches 52-Week High on Faster-Than-Expected Earnings Recovery

ROARABLE RATING BRIEF • RQD 63/100 (C) ✓ STAGE-C NUMBER FIREWALL VERIFIED

CNC — Centene Corporation: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5

As of: 2026-11-02T15:12:09Z

Roarable Rating Brief: What This Means to a Prospective Investor

The Roarable RQD score is 63 out of 100, graded C, with the verdict "Roarable Hold — Fair / Balanced Risk-Reward" (per the Roarable RQD rating). The five pillars are: Fundamental Cash Engine at 11/20, where ROIC of -31% is weak while FCF yield of 12.72% is strong; Whale 13F Flow at 16/20, reflecting institutional accumulation and options positioning; Insider Conviction at 12/20, based on SEC Form 4 and Congressional PTR cluster flow; Macro Regime Fit at 14/20, with beta of 0.94 and sector sensitivity; and Forensic Balance Sheet at 10/20, with Altman Z 2.52, Piotroski F 6/9, and Debt/Equity 0.87 (per the Roarable RQD rating).

For a prospective investor, the upside drivers are the high FCF yield and the positive institutional flow signal. The valuation tradeoffs are notable: forward P/E is 36 while trailing EPS is -13.48, and ROIC is -31%, so the cash-generation case rests on FCF rather than accounting earnings. The balance sheet is the weakest pillar relative to its cap, and insider conviction is middling. The overall verdict is balanced rather than decisive, which is consistent with a mixed set of signals. This is an analytical framing, not personalized advice.

Business

Centene Corporation (CNC) is a NYSE-listed issuer in the Health Care sector and the Medical Specialities industry (per the company profile). The source data does not describe its products, customers, or revenue model beyond sector and industry classification. Reported revenue, however, is shown in the financial history below.

Financial Trend

Period	Revenue	Operating Income	Net Income	EPS	FCF	Cash	Debt
FY 2025	$174581.0M	$-7623.0M	$-6674.0M	N/A	$4321.0M	$17888.0M	$17351.0M
FY 2024	$145505.0M	$3175.0M	$3305.0M	N/A	$-490.0M	$14063.0M	$18423.0M
FY 2023	$140095.0M	$2930.0M	$2702.0M	N/A	$1748.7M	N/A	$39338.7M

Per the SEC financials, FY 2025 swung to an operating loss and net loss after a profitable FY 2024. Reported margins are gross 8.1%, operating -4.4%, and net -3.8% (per the market data). ROIC is -31% and the Altman Z-Score is 2.52, with Piotroski F-Score 6/9 (per the Roarable RQD rating). Debt/Equity is 0.87 (per the Roarable RQD rating), and FY 2025 FCF of $4321.0M is positive, while FY 2024 FCF was negative.

Recent Catalysts & News Wire Analysis

Recent headlines (per the news and catalysts feed) are all tagged as market wire items with a YELLOW signal. They include a report that the stock is trading up, a report that the stock is approaching its 52-week high on faster-than-expected earnings recovery, and a preview of the Q3 2026 quarter that frames 2027 as a bridge. The feed items are aggregator summaries and do not provide specific fundamental detail. The butterfly supply-chain graph shows no supply-chain links and no proprietary signals.

Open Questions

What drove the swing from FY 2024 net income of $3305.0M to FY 2025 net loss of $-6674.0M, and is the reported EPS of N/A consistent with the net income line?
Why is trailing P/E and EV/EBITDA unavailable while forward P/E is 36, and what earnings base underlies that forward figure?
What explains the FY 2023 cash figure being N/A while debt was $39338.7M, and how has debt declined to $17351.0M by FY 2025?
What are the company's revenue sources and product mix, since the source data gives only sector classification?
What institutional, insider, or analyst positioning exists, given that holder and analyst data are absent?

CNC Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Centene Corporation (CNC) • Click "Debate This Headline" to argue it in the Roar Pit below

💬 Jump to CNC Debate Forum (3) ↓

🟡 MARKET WIRE Yahoo! Finance Canada • 6h ago

Centene Corporation (CNC) Stock Price, News, Quote & History

Yahoo! Finance Canada report covering Centene Corporation (CNC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Investing.com • 9h ago

Centene Stock Price Today | NYSE: CNC Live

Investing.com report covering Centene Corporation (CNC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE CNN • 12h ago

symbol__ Stock Quote Price and Forecast

CNN report covering Centene Corporation (CNC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 15h ago

Centene (CNC) Stock Trades Up, Here Is Why

Yahoo Finance report covering Centene Corporation (CNC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE TradingView • 18h ago

Centene Stock Approaches 52-Week High on Faster-Than-Expected Earnings Recovery

TradingView report covering Centene Corporation (CNC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Seeking Alpha • 21h ago

Centene Q3 2026 Preview: The Quarter Is Easy, The 2027 Bridge Is Not (NYSE:CNC)

Seeking Alpha report covering Centene Corporation (CNC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE marketscreener.com • 1d ago

Earnings Flash (CNC) Centene Corporation Posts Q3 Adjusted EPS $0.58 per Share

marketscreener.com report covering Centene Corporation (CNC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🟡 MARKET WIRE Yahoo Finance • 1d ago

Are Investors Undervaluing Centene (CNC) Right Now?

Yahoo Finance report covering Centene Corporation (CNC) market action, institutional positioning, and fundamental catalysts.

Read Full Source ↗

🔥 THE ROAR PIT • LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CNC Bull vs. Bear Conversation Board — What's Your Call at $68.45?

🐂 50% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CNC 🐻 50% BEARISH CONVICTION

RO RoarDesk_Moderator Roarable Research Desk ⚖️ DEBATE HOST 🎯 Target: $74.11 (+8.0%)

📌 Pinned Debate

🔥 Official Bull vs. Bear Debate: Is CNC (C • RQD 63/100) a Buy at $68.62?

Welcome to the CNC (Centene Corporation) Roar Pit. Current RQD Composite is 63/100 (Roarable Hold — Fair / Balanced Risk-Reward) in Medical Specialities. Bulls point to operating leverage and sector positioning, while bears focus on macro rate sensitivity and margin execution. Pick your side (🐂 Bull or 🐻 Bear) and drop your price target below.

FO ForensicBear Forensic Accounting Watch 🐻 BEARISH 🎯 Target: $53.52 (-22.0%)

Spot @ $68.62

Pump the brakes on CNC — check the valuation vs. margin headwinds

Everyone in here is repeating the bull case on CNC, but look at what you are paying: current EV/EBITDA multiples with 8.1% gross margins. Unless Centene Corporation expands free cash flow yield next quarter, I would rather wait for a pullback closer to the 200-day moving average before touching this.

QU QuantViper Verified K Arena Trader 🐂 BULLISH 🎯 Target: $82.34 (+20.0%)

Spot @ $68.62

CNC cash flow & RQD setup is being underpriced by the Street here

Looking at the 5-pillar RQD breakdown on CNC, the market is fixating on short-term headline noise in Medical Specialities and ignoring the balance sheet and cash flow trajectory. At $68.62 (52-wk range $31.63 - $72.50), any beat on forward guidance forces shorts and underweight funds to chase.